Healthcare & Life Sciences
Spirea
United Kingdom
activeseed
seed
Stage
1
Investors
About
Spirea is a biotech company developing next-generation antibody-drug conjugates (ADCs) for targeted cancer therapy, using a novel platform technology that increases drug-to-antibody ratios for improved efficacy and safety.
Explore Spirea's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.